Biomedical (basic)
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272200900060C
- Awardee
-
Janssen Vaccines & Prevention B.V. UEI VRE2EKNJTJJ4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $48,585,370
Award facts
- Contract value 48% obligated
-
- $79,361,174.00 Current, with exercised options
- $100,958,063.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 35 offers Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Netherlands
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,805,323 | |
| Other Administrative Action | -$2,744,776 | |
| Funding Only Action | -$3,443,328 | |
| Exercise an Option | $10,786,489 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $2,890,759 | |
| Exercise an Option | $6,793,212 | |
| Funding Only Action | $1,324,994 | |
| Funding Only Action | $10,007,539 | |
| Funding Only Action | $17,529,202 | |
| Original award | $13,246,602 |
Show all 12
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Janssen Vaccines & Prevention B.V. (doing business as JPC), a foreign-owned for-profit organization. The contract is for the "Application of Platform Technologies for the Development of Therapeutics for Biodefense" and has a ceiling value of $100,958,063.00. The contract type is Cost Plus Fixed Fee, with an ultimate completion date of August 14, 2014. The contract was awarded on August 15, 2009 and was not set aside. This contract appears to be part of the agency's broader biomedical research and development efforts.
Quick answers
Who was awarded contract HHSN272200900060C?
HHSN272200900060C was awarded to Janssen Vaccines & Prevention B.V. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 15, 2009.
How much is contract HHSN272200900060C worth?
The government has obligated $48,585,370 on HHSN272200900060C. Its current value, with exercised options, is $79,361,174. Its potential value, with all options, is $100,958,063.
Was contract HHSN272200900060C competed?
The extent of competition for HHSN272200900060C was full and open competition. The government received 35 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award